Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation

Stefan O. Ciurea; Doris Soebbing; Gabriela Rondón; Kai Cao; Gheath Alatrash; Sairah Ahmed; Uday Popat; Betül Oran; Qaiser Bashir; Partow Kebriaei

doi:10.1182/blood.v130.suppl_1.3179.3179

Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation

Identifier:nobleid.org/w1/20260515/56DC2201

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/56DC2201.svg?ark=w1%2F20260515%2F56DC2201)](https://nobleid.org/work/w1/20260515/56DC2201)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation

Identifier:nobleid.org/w1/20260515/56DC2201

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/56DC2201.svg?ark=w1%2F20260515%2F56DC2201)](https://nobleid.org/work/w1/20260515/56DC2201)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work